Intravesical Bacillus Calmette–Guerin (BCG) immunotherapy is a proven, effective treatment for intermediate- and high-risk non-muscle-invasive bladder cancer. Minor side effects are common and expected but systemic effects can occur in < 5% of treated patients. We present a rare case of a 49-year-old male that presented with fever and chills after 3 weeks of intravesical BCG therapy post transurethral resection of bladder tumor. New renal lesions were present on contrast-enhanced computed tomography scan which was histologically proven to be necrotizing renal granulomatosis.
Digital Object Identifier (DOI)
Tran-Harding, Karen; Nair, Rashmi T.; and Ganesh, Halemane S., "Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-Muscle-Invasive Bladder Cancer" (2018). Radiology Faculty Publications. 14.